5AM Partners VI, LLC

Insider Reports History

Location
4 Embarcadero Center, Suite 3110, San Francisco, CA
Signature
5AM Partners VI, LLC, By /s/ Kush Parmar, Managing Member
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by 5AM Partners VI, LLC:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Enliven Therapeutics, Inc. 10%+ Owner Common Stock 3.2M $47.7M $14.90 Feb 14, 2024 By 5AMVentures VI, L.P.
Enliven Therapeutics, Inc. 10%+ Owner Common Stock 635K $9.47M $14.90 Feb 14, 2024 By 5AM Opportunities I, L.P.
Camp4 Therapeutics Corp 10%+ Owner Common Stock 2.63M $5.3M $2.02 Sep 11, 2025 By 5AM Ventures VI, L.P.
Camp4 Therapeutics Corp 10%+ Owner Common Stock 2.94M $4.5M $1.53 Sep 11, 2025 By 5AM Ventures VII, L.P.
Camp4 Therapeutics Corp 10%+ Owner Common Stock 303K $612K $2.02 Sep 11, 2025 By 5AM Opportunities II, L.P.
Artiva Biotherapeutics, Inc. 10%+ Owner Common Stock 1.18M Jul 22, 2024 By 5AM Opportunities II, L.P.
Artiva Biotherapeutics, Inc. 10%+ Owner Common Stock 1.17M Jul 22, 2024 By 5AM Ventures VI, L.P.
Artiva Biotherapeutics, Inc. 10%+ Owner Series A Preferred Stock 0 Jul 22, 2024 By 5AM Ventures VI, L.P.
Artiva Biotherapeutics, Inc. 10%+ Owner Series B Preferred Stock 0 Jul 22, 2024 By 5AM Ventures VI, L.P.
Camp4 Therapeutics Corp 10%+ Owner Series A Prime Preferred Stock 0 Oct 15, 2024 By 5AM Ventures VI, L.P.
Camp4 Therapeutics Corp 10%+ Owner Series B Preferred Stock 0 Oct 15, 2024 By 5AM Opportunities II, L.P.
Camp4 Therapeutics Corp 10%+ Owner Series B Preferred Stock 0 Oct 15, 2024 By 5AM Ventures VI, L.P.
CinCor Pharma, Inc. 10%+ Owner Common Stock 0 $28.75 Feb 24, 2023 By 5AM Opportunities II, L.P.
CinCor Pharma, Inc. 10%+ Owner Common Stock 0 $28.75 Feb 24, 2023 By 5AM Opportunities I, L.P.
CinCor Pharma, Inc. 10%+ Owner Common Stock 0 $28.75 Feb 24, 2023 By 5AM Ventures VI, L.P.

Insider Reports Filed by 5AM Partners VI, LLC

Symbol Company Period Transactions Value $ Form Type Date Filed Role
CAMP Camp4 Therapeutics Corp Sep 11, 2025 1 $4.5M 4 Sep 15, 2025 10%+ Owner
CAMP Camp4 Therapeutics Corp Oct 15, 2024 6 $10M 4 Oct 15, 2024 10%+ Owner
CAMP Camp4 Therapeutics Corp Oct 10, 2024 0 $0 3 Oct 10, 2024 10%+ Owner
ARTV Artiva Biotherapeutics, Inc. Jul 22, 2024 6 $14.7M 4 Jul 24, 2024 10%+ Owner
ARTV Artiva Biotherapeutics, Inc. Jul 18, 2024 0 $0 3 Jul 18, 2024 10%+ Owner
ELVN Enliven Therapeutics, Inc. Feb 14, 2024 2 -$12.3M 4 Feb 16, 2024 10%+ Owner
ELVN Enliven Therapeutics, Inc. Jan 31, 2024 2 -$7.5M 4 Feb 2, 2024 10%+ Owner
ELVN Enliven Therapeutics, Inc. Sep 26, 2023 2 -$2.96M 4 Sep 28, 2023 10%+ Owner
ELVN Enliven Therapeutics, Inc. Aug 24, 2023 2 -$7.04M 4 Aug 28, 2023 10%+ Owner
CINC CinCor Pharma, Inc. Feb 24, 2023 3 $0 4 Feb 28, 2023 10%+ Owner
ELVN Enliven Therapeutics, Inc. Feb 23, 2023 0 $0 3 Mar 6, 2023 10%+ Owner
CINC CinCor Pharma, Inc. Aug 15, 2022 2 $18M 4 Aug 17, 2022 10%+ Owner
CINC CinCor Pharma, Inc. Jan 11, 2022 7 $7.52M 4 Jan 13, 2022 10%+ Owner
CINC CinCor Pharma, Inc. Jan 6, 2022 0 $0 3 Jan 6, 2022 10%+ Owner